deepeye Medical has announced CE Mark approval for its AI-powered Therapy Planning Support platform,...

Bausch + Lomb has officially launched LUMIFY Preservative Free, an over-the-counter (OTC) redness re...

Ashvattha Therapeutics has announced encouraging interim results from its phase 2 trial evaluating m...

Viridian Therapeutics has announced encouraging long-term durability data from its phase 3 THRIVE cl...

Sylentis has released promising topline results from its phase 2a study evaluating SYL1801, an inves...

Atsena Therapeutics has shared encouraging interim data from Part A of its phase 1/2 LIGHTHOUSE clin...

Nicox has announced results from the Whistler Phase 3b exploratory trial, evaluating the intraocular...

Bausch + Lomb has officially launched Zenlens CHROMA HOA in the United States—a custom, wavefront-gu...

Cognition Therapeutics has announced topline results from its Phase 2 Magnify study, evaluating the ...

At the 2025 ARVO Annual Meeting in Salt Lake City, a multi-stakeholder coalition announced the offic...